JP2002542157A5 - - Google Patents

Download PDF

Info

Publication number
JP2002542157A5
JP2002542157A5 JP2000604070A JP2000604070A JP2002542157A5 JP 2002542157 A5 JP2002542157 A5 JP 2002542157A5 JP 2000604070 A JP2000604070 A JP 2000604070A JP 2000604070 A JP2000604070 A JP 2000604070A JP 2002542157 A5 JP2002542157 A5 JP 2002542157A5
Authority
JP
Japan
Prior art keywords
gpr
antigen
antibody
binding
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000604070A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002542157A (ja
JP5112578B2 (ja
Filing date
Publication date
Priority claimed from US09/266,464 external-priority patent/US6329159B1/en
Application filed filed Critical
Publication of JP2002542157A publication Critical patent/JP2002542157A/ja
Publication of JP2002542157A5 publication Critical patent/JP2002542157A5/ja
Application granted granted Critical
Publication of JP5112578B2 publication Critical patent/JP5112578B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000604070A 1999-03-11 2000-03-10 抗ｇｐｒ−９−６および抗ｔｅｃｋ抗体ならびにｇｐｒ−９−６およびｔｅｃｋの機能の調節因子の同定方法。 Expired - Lifetime JP5112578B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/266,464 1999-03-11
US09/266,464 US6329159B1 (en) 1999-03-11 1999-03-11 Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
PCT/US2000/006240 WO2000053635A1 (en) 1999-03-11 2000-03-10 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011178577A Division JP5933204B2 (ja) 1999-03-11 2011-08-17 抗ｇｐｒ−９−６および抗ｔｅｃｋ抗体ならびにｇｐｒ−９−６およびｔｅｃｋの機能の調節因子の同定方法

Publications (3)

Publication Number Publication Date
JP2002542157A JP2002542157A (ja) 2002-12-10
JP2002542157A5 true JP2002542157A5 (enExample) 2007-04-05
JP5112578B2 JP5112578B2 (ja) 2013-01-09

Family

ID=23014693

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000604070A Expired - Lifetime JP5112578B2 (ja) 1999-03-11 2000-03-10 抗ｇｐｒ−９−６および抗ｔｅｃｋ抗体ならびにｇｐｒ−９−６およびｔｅｃｋの機能の調節因子の同定方法。
JP2011178577A Expired - Lifetime JP5933204B2 (ja) 1999-03-11 2011-08-17 抗ｇｐｒ−９−６および抗ｔｅｃｋ抗体ならびにｇｐｒ−９−６およびｔｅｃｋの機能の調節因子の同定方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011178577A Expired - Lifetime JP5933204B2 (ja) 1999-03-11 2011-08-17 抗ｇｐｒ−９−６および抗ｔｅｃｋ抗体ならびにｇｐｒ−９−６およびｔｅｃｋの機能の調節因子の同定方法

Country Status (7)

Country Link
US (6) US6329159B1 (enExample)
EP (1) EP1157043B2 (enExample)
JP (2) JP5112578B2 (enExample)
AT (1) ATE517123T1 (enExample)
AU (1) AU771603B2 (enExample)
CA (1) CA2365230C (enExample)
WO (1) WO2000053635A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2333951C (en) * 1998-06-01 2012-02-28 Ortho-Mcneil Pharmaceutical, Inc. Method for treating neurodegenerative disorders
US20050100548A1 (en) * 2001-07-24 2005-05-12 Biogen Idec Ma Inc. BAFF, inhibitors thereof and their use in the modulation of B-cell response
US6329159B1 (en) 1999-03-11 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
US6698636B2 (en) * 2000-09-28 2004-03-02 June Angus Waist pouch
US7468253B2 (en) * 2001-06-07 2008-12-23 Chemocentryx, Inc. Method for multiple chemokine receptor screening for antagonists using RAM assay
DE60216606T2 (de) * 2001-06-07 2007-04-05 Chemocentryx Inc., Mountain View Zellwanderungsassay
NO20013192L (no) * 2001-06-25 2002-12-27 Medinnova As Metode for monitering av T-celler
US7871619B2 (en) * 2001-11-30 2011-01-18 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7413866B2 (en) * 2001-11-30 2008-08-19 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7442512B2 (en) * 2001-11-30 2008-10-28 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7253007B2 (en) * 2001-11-30 2007-08-07 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
WO2003095967A2 (en) * 2002-05-14 2003-11-20 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)
EP1507756B1 (en) 2002-05-24 2015-07-22 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
US20120135415A1 (en) * 2002-11-15 2012-05-31 Morehouse School Of Medicine Detecting cancer with anti-cxcl13 and anti-cxcr5 antibodies
US9233120B2 (en) 2002-11-15 2016-01-12 Jyant Technologies Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration
US8512701B2 (en) 2002-11-15 2013-08-20 Morehouse School Of Medicine Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration
WO2004045525A2 (en) * 2002-11-15 2004-06-03 Morehouse School Of Medicine Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation.
US7919083B2 (en) * 2002-11-15 2011-04-05 Morehouse School Of Medicine Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
US8658377B2 (en) 2002-11-15 2014-02-25 Morehouse School Of Medicine Detecting cancer with anti-CCL25 and anti-CCR9 antibodies
CN1747929B (zh) * 2002-12-20 2010-04-28 坎莫森特里克斯公司 趋化因子i-tac或sdf-1结合于ccxckr2受体的抑制剂
CA2522957C (en) 2003-04-23 2013-10-22 Medarex, Inc. Compositions and methods for the therapy of inflammatory bowel disease
US20100247540A1 (en) * 2003-10-30 2010-09-30 Chemocentryx, Inc. Methods and Compositions For Modulating Angiogenesis
EP1745288A2 (en) * 2004-04-16 2007-01-24 Genentech, Inc. Assay for antibodies
JP5160887B2 (ja) 2004-06-21 2013-03-13 メダレックス インコーポレイテッド インターフェロンアルファレセプター１抗体及びその使用法
ES2434852T3 (es) * 2005-04-21 2013-12-17 Chemocentryx, Inc. Anticuerpos que se unen a CCX-CKR2
CN104797933A (zh) 2012-09-07 2015-07-22 阿尔伯达大学董事会 用于诊断发炎性肝病的方法和组合物
EP2876114A1 (en) * 2013-11-25 2015-05-27 Consejo Superior De Investigaciones Científicas Antibodies against CCR9 and applications thereof
WO2017140803A1 (en) 2016-02-16 2017-08-24 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Modulators of tumor immune resistance for the treatment of cancer
US20190054110A1 (en) 2016-02-16 2019-02-21 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Modulators of ccr9 for treating tumor resistance to immune responses
CA3046489A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
EP3554541B1 (en) 2016-12-14 2023-06-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
CN116726361A (zh) 2018-11-19 2023-09-12 比奥拉治疗股份有限公司 用生物治疗剂治疗疾病的方法和装置
WO2021119482A1 (en) 2019-12-13 2021-06-17 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
WO2023148346A1 (en) 2022-02-03 2023-08-10 Sunrock Biopharma S.L Combination therapy comprising anti-ccr9 antibody and vincristine for cancer
JP7368678B1 (ja) * 2023-04-26 2023-10-25 イミュニティリサーチ株式会社 Ｃｄ４＋ｔ細胞集団中の特定の細胞亜集団の相対量の測定方法
EP4578874A1 (en) * 2023-12-29 2025-07-02 SunRock Biopharma S.L. Anti-ccr9 antibody

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US18167A (en) * 1857-09-08 Improvement in blast-furnaces
US5440021A (en) * 1991-03-29 1995-08-08 Chuntharapai; Anan Antibodies to human IL-8 type B receptor
US5652133A (en) 1993-01-28 1997-07-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloning and expression of the human macrophage inflammatory protein-1.alpha.α) /rantes receptor
EP0883687B1 (en) * 1996-03-01 2004-10-27 Euroscreen S.A. C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses
US5981231A (en) 1996-06-17 1999-11-09 Human Genome Sciences, Inc. Polynucleotides encoding chemokine β-15
AU738116B2 (en) 1996-06-17 2001-09-06 Human Genome Sciences, Inc. Chemokine beta-15
WO1998001557A2 (en) 1996-07-05 1998-01-15 Schering Corporation Mammalian chemokine reagents
US6723520B2 (en) * 1996-07-05 2004-04-20 Schering Corporation Antibodies that bind chemokine teck
DE69737656T2 (de) * 1996-09-10 2008-01-03 Theodor Kocher Institut Cxcr3 chemokine rezeptor, antikoerper, nukleinsaeure und deren verfahren zur anwendung
WO1998032858A2 (en) 1997-01-23 1998-07-30 Schering Corporation Mammalian chemokines; receptors; reagents; uses
EP0878542A3 (en) * 1997-04-22 2000-04-19 Smithkline Beecham Corporation cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
CA2299619A1 (en) * 1997-08-06 1999-02-18 Regeneron Pharmaceuticals, Inc. Human orphan receptor ntr-1
US6329159B1 (en) 1999-03-11 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
YU78601A (sh) * 1999-05-05 2005-07-19 Aventis Pharma Deutschland Gmbh. 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže
WO2001049325A2 (en) * 2000-01-07 2001-07-12 Stichting Klinische Farmacologie Groningen Gene therapy to promote angiogenesis and/or the treatment of heart failure
DK1798223T4 (da) 2002-11-18 2014-09-22 Chemocentryx Inc Arylsulfonamider

Similar Documents

Publication Publication Date Title
JP2002542157A5 (enExample)
Townson et al. Characterization of mouse CCX‐CKR, a receptor for the lymphocyte‐attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP‐3β/mCCL19: comparison to human CCX‐CKR
US5519118A (en) Human MDM2 protein involved in human tumors
US6689566B1 (en) Methods, kits, and antibodies for detecting parathyroid hormone
HRP931147A2 (hr) Metoda za rano otkrivanje, otkrivanje ozbiljnosti i za popratnu procijenu tijeka sepse pri samom tretmanu iste i sredstva za provođenje spomenute metode
JPWO2003085399A1 (ja) 白血病、前白血病または非白血病性悪性血液疾患の判定方法及び診断薬
US20160084852A1 (en) Methods of determination of activation or inactivation of atrial natriuretic peptide (anp) and brain natriuretic peptide (bnp) hormonal systems
JP2010190572A (ja) ＩＬ１３Ｒａ２に対する抗体およびこれを含む診断・治療薬
WO1994017197A1 (fr) ANTICORPS DIRIGE CONTRE LE β-AMYLOIDE OU UN DERIVE DE CE DERNIER ET SON UTILISATION
JP2022028790A (ja) 腎疾患及び歯周疾患を検出及び診断するための方法及び組成物
JP2004512006A5 (enExample)
JP2012058048A (ja) ペリオスチン測定の正確性の改善方法
WO2001022085A1 (en) Method of fractional measurement of soluble cd14 protein
WO1999043710A1 (en) Prostate-specific membrane antigens and methods of making and using
CN121358774A (zh) 与nkg2a结合的抗体或抗原结合片段及其用途
WO2000050457A1 (en) Prostate-specific membrane antigens and methods of making and using
US7033787B2 (en) Isolated cytokine receptor LICR-2
JP3920573B2 (ja) トランスフェリン受容体様蛋白質をコードする核酸、及びその関連産物
Smith Autoantibodies to the TSH Receptor—from discovery to understanding the mechanisms of action and to new therapeutics
WO2022102744A1 (ja) ＳＡＲＳ－ＣｏＶ－２のスパイクタンパク質に対する抗体
CA2387576C (en) Immuno-interactive fragments of the .alpha.c subunit of inhibin
JP3425146B2 (ja) ヒトｔｎｆ結合タンパク質▲ｉ▼（ｔｎｆ−ｂｐ▲ｉ▼）に対するモノクローナル抗体
JP4346540B2 (ja) 絨毛外栄養膜細胞特異的蛋白質
US20090018071A1 (en) Epididymis-specific receptor protein
EP2272872A1 (en) Monoclonal antibody specifically recognizing human interferon alpha subtype alpha-8 and mutant protein thereof